Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Despite promising preclinical data, clinical trials in humans are extremely limited, and the compound remains largely experimental, with ongoing research required to fully characterize pharmacokinetics, optimal dosing, long-term safety, and potential off-target effects.
With the new HoMEso GHK-Cu Rejuvenation Kit, we wanted to take that story one step further
These technologies potentially allow the setup of an in vitro test system, which resembles the in vivo situation as closely as possible 27
Guidelines for Safe Administration and Storage of Peptide Compounds in Research and Clinical Practice
Now that we have forged links with the BSH we look forward to being involved in all manner of activities in the future
